ASR Nederland (ASRNL) H1 2024 earnings summary

Executive summary

• Operating result rose 47% to €677 million, driven by strong performance across all segments and the integration of Aegon Nederland/Aegon NL.

• Net result turned negative (€-67 million to €-70 million) due to negative investment revaluations and Knab sale-related items.

• Premium and Defined Contribution (DC) inflow increased by 29% to €5,393 million, with significant growth in both Non-life and Life segments.

• Integration of Aegon Nederland/Aegon NL is progressing well, with key milestones achieved and synergy targets on track.

• Interim dividend set at €1.16 per share, up 7% and representing 40% of the prior year’s full-year dividend.

Financial highlights

• Operating result up €217 million to €677 million year-over-year; OCC increased 59% to €658 million.

• Solvency II ratio improved to 181% (from 176%), pro forma 196% post-Knab transaction and Tier 2 redemption.

• Combined ratio Non-life improved to 91.8% (HY 2023: 92.4%), ahead of target range.

• Premiums received in Non-life up 16.6% to €2.4 billion; DC inflow up 80.5% to €1.3 billion.

• Operating expenses increased by 94% to €705 million, mainly due to Aegon Nederland integration.

Outlook and guidance

• On track to achieve medium-term OCC target of €1.35 billion by 2026 and Solvency II ratio >160%.

• Combined ratio P&C and Disability target: 92–94%; organic premium growth 3–5% annually.

• Sale of Knab expected to close in H2 2024, projected to add 17 percentage points to Solvency II ratio.

• Pension DC and annuity inflows ramping up, supporting long-term growth targets.

• Integration synergies and cost savings expected to continue, with at least €250 million targeted.